A1ZN34:BVMF
Astrazeneca Plc Bdr
R$ 139.90
arrow_downward
-1.42%(-2.01) 1D
10-р сарын 16, 17:06:00 (GMT-3) · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
R$ 143.33
High
R$ 143.33
Low
R$ 138.81
Mkt. cap
259.57Т
Avg. vol.
892.00
Volume
1.25 мян
52-wk high
R$ 190.40
52-wk low
R$ 129.06
Shares outstanding
1.55 тэрбум
No. of employees
96 мян
Open
R$ 143.33
High
R$ 143.33
Low
R$ 138.81
Mkt. cap
259.57Т
Avg. vol.
892.00
Volume
1.25 мян
52-wk high
R$ 190.40
52-wk low
R$ 129.06
Shares outstanding
1.55 тэрбум
No. of employees
96 мян
News stories
From web sources and news partners
Insider Monkey
·
8 цагийн өмнө
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
Traders Union
·
15 цагийн өмнө
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
JournalArta
·
21 цагийн өмнө
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
Reuters
·
1 өдрийн өмнө
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96.1 мян
Founded1999 оны 4-р сарын 6
HeadquartersCambridge, Cambridgeshire, Их Британи
SectorPharmaceutical industry
Websiteastrazeneca.com